Phendimetrazine Brown/Clear Capsules recalled over manufacturing violations
- Recall date
- July 27, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Calvin Scott & Company, Inc. recalls Phendimetrazine Brown/Clear Capsules, 105 mg, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquer…
- Recall number
- D-1523-2020
- FDA classification
- Class II
- Brand / firm
- Calvin Scott & Company, Inc.
- Sold / distributed
- Nationwide within the United States
Why it was recalled
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Phendimetrazine Brown/Clear Capsules, 105 mg, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Virtus Pharm., LLC Newtown, PA 18940; NDC 69543-0409-11
Get recall alerts
Free email alert whenever Calvin Scott & Company, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Calvin Scott & Company, Inc.